# aTyr Pharma (ATYR) - Q2 2026 earnings

Reported August 7, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $189.6M | Not available |
| EPS | $-0.11 | $-0.12 |

Earnings filing reader: [8-K 0001339970-26-000051](https://www.opencapital.sh/filings/0001339970-26-000051)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001339970-26-000051.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1339970/000133997026000051/0001339970-26-000051-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1339970/000133997026000053/0001339970-26-000053-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/atyr/earnings/q2-2026